Why the study?
Does recombinant human megakaryocyte growth and development factor (MGDF) affect platelet activation and aggregation?
Population
Platelets in platelet-rich plasma (PRP) and whole blood
Comparison
Recombinant human megakaryocyte growth and… vs Agonists alone without MGDF preincubation
Design
Preclinical
Authors
Loading...
May warrant caution with MGDF due to platelet priming; leaves open clinical relevance in humans.
Does recombinant human megakaryocyte growth and development factor (MGDF) affect platelet activation and aggregation?
MGDF primes platelets for enhanced activation by other agonists, suggesting that thrombopoietin plays a physiologic role in modulating platelet hemostatic potential.
Montrucchio et al. (1996) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: